107 related articles for article (PubMed ID: 18945767)
21. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
22. Presence of prelymphoma cells in the bone marrow of the lymphomagenic virus-treated AKR mouse.
Takeuchi H; Kato A; Hays EF
Cancer Res; 1984 Mar; 44(3):1008-11. PubMed ID: 6198077
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional control of muscle plasticity: differential regulation of troponin I genes by electrical activity.
Calvo S; Stauffer J; Nakayama M; Buonanno A
Dev Genet; 1996; 19(2):169-81. PubMed ID: 8900050
[TBL] [Abstract][Full Text] [Related]
24. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box.
Suzuki T; Hirai H; Fujisawa J; Fujita T; Yoshida M
Oncogene; 1993 Sep; 8(9):2391-7. PubMed ID: 8361755
[TBL] [Abstract][Full Text] [Related]
25. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
26. Non-identical patterns of proviral insertions around host transcription units in lymphomas induced by different strains of murine leukemia virus.
Martín-Hernández J; Balle Sørensen A; Pedersen FS
Virology; 2006 Sep; 353(1):193-9. PubMed ID: 16790256
[TBL] [Abstract][Full Text] [Related]
27. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
Geisen C; Karsunky H; Yücel R; Möröy T
Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
[TBL] [Abstract][Full Text] [Related]
28. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity.
LoSardo JE; Boral AL; Lenz J
J Virol; 1990 Apr; 64(4):1756-63. PubMed ID: 2157056
[TBL] [Abstract][Full Text] [Related]
29. Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.
Martiney MJ; Levy LS; Lenz J
J Virol; 1999 Mar; 73(3):2143-52. PubMed ID: 9971797
[TBL] [Abstract][Full Text] [Related]
30. Virulence in lymphomagenesis is modulated by alterations in proteins binding to CORE and GRE-LVa elements of the MoMuLV enhancer.
Yuen PH; Khang YH; Matherne C
Leukemia; 1992; 6 Suppl 3():76S-82S. PubMed ID: 1602832
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes.
Dabrowska MJ; Ejegod D; Lassen LB; Johnsen HE; Wabl M; Pedersen FS; Dybkær K
Leuk Res; 2013 Oct; 37(10):1383-90. PubMed ID: 23896059
[TBL] [Abstract][Full Text] [Related]
32. Antisense transcription in gammaretroviruses as a mechanism of insertional activation of host genes.
Rasmussen MH; Ballarín-González B; Liu J; Lassen LB; Füchtbauer A; Füchtbauer EM; Nielsen AL; Pedersen FS
J Virol; 2010 Apr; 84(8):3780-8. PubMed ID: 20130045
[TBL] [Abstract][Full Text] [Related]
33. Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.
Dabrowska MJ; Dybkaer K; Johnsen HE; Wang B; Wabl M; Pedersen FS
J Virol; 2009 Aug; 83(16):8051-61. PubMed ID: 19474094
[TBL] [Abstract][Full Text] [Related]
34. Activation of the brain-specific neurogranin gene in murine T-cell lymphomas by proviral insertional mutagenesis.
Nielsen AA; Kjartansdóttir KR; Rasmussen MH; Sørensen AB; Wang B; Wabl M; Pedersen FS
Gene; 2009 Aug; 442(1-2):55-62. PubMed ID: 19376211
[TBL] [Abstract][Full Text] [Related]
35. Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.
Ejegod D; Sørensen KD; Mossbrugger I; Quintanilla-Martinez L; Schmidt J; Pedersen FS
J Virol; 2009 Jan; 83(1):336-46. PubMed ID: 18945767
[TBL] [Abstract][Full Text] [Related]
36. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
37. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
38. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
39. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines.
Nielsen AL; Nørby PL; Pedersen FS; Jørgensen P
J Virol; 1996 Sep; 70(9):5893-901. PubMed ID: 8709209
[TBL] [Abstract][Full Text] [Related]
40. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.
Ethelberg S; Tzschaschel BD; Luz A; Diaz-Cano SJ; Pedersen FS; Schmidt J
J Virol; 1999 Dec; 73(12):10406-15. PubMed ID: 10559359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
